New research reveals GLP-1 drugs like Ozempic may reduce stroke risk and improve recovery. At the 22nd Annual Meeting of the Society of NeuroInterventional Surgery (SNIS), three new studies were presented that explored whether GLP-1 inhibitors could help reduce the risk of stroke or limit the severity of brain damage following a stroke. These medications […]



Summary

Recent research presented at the SNIS meeting suggests GLP-1 drugs, like Ozempic, may offer benefits in stroke prevention and recovery. Three studies indicated potential for these medications to reduce stroke risk and limit brain damage after a stroke. While the details of the studies weren’t fully disclosed, the findings point towards a possible neuroprotective effect of GLP-1 inhibitors. This opens new avenues for exploring these drugs beyond their current use in diabetes and weight management, potentially improving outcomes for stroke patients. Further research is needed to confirm these promising initial observations.

Read more…

This post is part of “Science and Technology News”, Follow for more…!!!

Credits: Source

Disclaimer